Thobois S - Search Results

1

LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.

Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group; Bonnet AM, Borg M, Broussolle E, Damier P, Destée A, Martinez M, Penet C, Rasco O, Tison F, Tranchan C, Vérin M. Lesage S, et al. Among authors: thobois s. Arch Neurol. 2007 Mar;64(3):425-30. doi: 10.1001/archneur.64.3.425. Arch Neurol. 2007. PMID: 17353388

2

Overactivation of primary motor cortex is asymmetrical in hemiparkinsonian patients.

Thobois S, Dominey P, Decety J, Pollak P, Gregoire MC, Broussolle E. Thobois S, et al. Neuroreport. 2000 Mar 20;11(4):785-9. doi: 10.1097/00001756-200003200-00026. Neuroreport. 2000. PMID: 10757520

3

Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET study.

Thobois S, Dominey PF, Decety J, Pollak PP, Gregoire MC, Le Bars PD, Broussolle E. Thobois S, et al. Neurology. 2000 Oct 10;55(7):996-1002. doi: 10.1212/wnl.55.7.996. Neurology. 2000. PMID: 11061258

4

Intravenous hypertrophic Paccioni granulations: differentiation from venous dural thrombosis.

Giraud P, Thobois S, Hermier M, Broussolle E, Chazot G. Giraud P, et al. Among authors: thobois s. J Neurol Neurosurg Psychiatry. 2001 May;70(5):700-1. doi: 10.1136/jnnp.70.5.700. J Neurol Neurosurg Psychiatry. 2001. PMID: 11309474 Free PMC article. No abstract available.

5

Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy.

Thobois S, Broussolle E, Toureille L, Vial C. Thobois S, et al. Mov Disord. 2001 Jul;16(4):764-5. doi: 10.1002/mds.1101. Mov Disord. 2001. PMID: 11481708

6

Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.

Thobois S, Guillouet S, Broussolle E. Thobois S, et al. Neurophysiol Clin. 2001 Oct;31(5):321-40. doi: 10.1016/s0987-7053(01)00273-8. Neurophysiol Clin. 2001. PMID: 11817273 Review.

7

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, Chazot G, Broussolle E, Sindou M. Thobois S, et al. J Neurol. 2002 May;249(5):529-34. doi: 10.1007/s004150200059. J Neurol. 2002. PMID: 12021940 Clinical Trial.

8

CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): a neurovascular disease diagnosed by ultrastructural examination of the skin.

Kanitakis J, Thobois S, Claudy A, Broussolle E. Kanitakis J, et al. Among authors: thobois s. J Cutan Pathol. 2002 Sep;29(8):498-501. doi: 10.1034/j.1600-0560.2002.290808.x. J Cutan Pathol. 2002. PMID: 12207744

9

The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation.

Thobois S, Corvaisier S, Mertens P, Di Guardo C, Mollion H, Guenot M, Rochefort F, Chazot G, Sindou M, Broussolle E. Thobois S, et al. Eur Neurol. 2003;49(1):59-63. doi: 10.1159/000067028. Eur Neurol. 2003. PMID: 12464720

10

Effects of subthalamic nucleus stimulation on actual and imagined movement in Parkinson's disease : a PET study.

Thobois S, Dominey P, Fraix V, Mertens P, Guenot M, Zimmer L, Pollak P, Benabid AL, Broussolle E. Thobois S, et al. J Neurol. 2002 Dec;249(12):1689-98. doi: 10.1007/s00415-002-0906-y. J Neurol. 2002. PMID: 12529791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters